Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis

Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis

Abstract Background Graft-versus-host disease (GvHD) is the main life-threatening complication of allogeneic hematopoietic stem cell transplantation (HSCT). Thirty to 80% of GvHD patients do not respond to first-line treatment and a second-line treatment is not universally established. Based on thei...

Full description

Bibliographic Details
Main Authors: Cynthia Morata-Tarifa, María del Mar Macías-Sánchez, Antonio Gutiérrez-Pizarraya, Rosario Sanchez-Pernaute
Format: Article
Language:English
Published: BMC 2020-02-01
Series:Stem Cell Research & Therapy
Subjects:
Meta-analysis
Acute graft-versus-host disease
Chronic graft-versus-host disease
Mesenchymal stromal cells
Prophylaxis
Treatment
Online Access:http://link.springer.com/article/10.1186/s13287-020-01592-z

Internet

http://link.springer.com/article/10.1186/s13287-020-01592-z

Similar Items